Latest news

Clinical Trials – August 17, 2026

Cereno Scientific activates first clinical site in global Phase IIb trial

The first clinical site has been activated in the company’s global Phase IIb EPIMODE trial evaluating lead drug candidate CS1 in pulmonary arterial hypertension (PAH).

Collaboration – August 17, 2026

Nordic research network aims to strengthen our region’s position in advanced microscopy

The network has researchers from Iceland, Norway, Sweden, Finland and Denmark. “It is absolutely crucial that we work together in the Nordic Region, because this is a rapidly developing scientific field, and when we join forces across the Nordic countries, we can compare ourselves with larger countries such as France, Germany and Italy. The Nordic […]

Careers article – August 14, 2026

Back to work: 10 tips for a smooth transition

Returning to work after a long, relaxing vacation can be challenging. Here are some tips to make the transition easier and less stressful.

Financing – August 14, 2026

AlzeCure receives upfront payment of USD 12 million and completes initial transaction with QuantumCell

AlzeCure Pharma has now received the full upfront payment of USD 12 million from the Danish biotech company QuantumCell.

Agreement – August 13, 2026

Zealand Pharma enters into royalty purchase and sale agreement with Royalty Pharma

Zealand Pharma has entered into a royalty purchase and sale agreement with Royalty Pharma in exchange for Zealand Pharma’s economics related to rusfertide (PTG-300), a potential first-in-class therapy for polycythemia vera, a rare and chronic blood disorder.

We Value Your Privacy

This site uses cookies

We use cookies to improve your experience on our site. By clicking "accept," you agree to our use of cookies.

Read more about our privacy policy

Only necessary
Accept All
Manage Cookies

Manage Cookies

functional

The "Functional" cookie category includes cookies that are essential for the smooth operation of our website and to enhance your browsing experience. These cookies enable various functionalities that make our site more user-friendly and efficient.

market

The "Market" cookie category encompasses cookies used to analyze and improve our marketing efforts. These cookies help us understand how you interact with our website and provide us with insights to optimize our content and advertisements, ensuring they are relevant to your interests.

personal

The "Personal" cookie category includes cookies that enhance the user experience by storing information about your preferences and interactions on our site. This allows us to tailor content and recommendations to your individual needs, providing a more personalized and engaging experience.